Peer-reviewedCC BY 4.0Molecular & Cellular Proteomics
SLC35A3 remodels site-specific N-glycosylation and defines a druggable glycosylation target in hepatocellular carcinoma
Related
- Transcriptomic analysis uncovers dysregulated glycosylation pathways in clear cell renal cell carcinoma
- Semaglutide Remodels the Gut Microbiome Beyond Its Appetite-Suppressing Action: Sex-Specific Gut-Brain Axis Implications.
- MUTYH knockdown suppresses the growth of hepatocellular carcinoma cells and modulates their response to chemotherapy
- B Cell Deficiency Protects Against the Development of c‐MET and Beta‐Catenin Driven Hepatocellular Carcinoma in Mice
- Stromal or exosome derived lncRNAs regulate stemness in hepatocellular carcinoma
BibTeX
@article{ouyang2026slc35a3,
title = {{SLC35A3 remodels site-specific N-glycosylation and defines a druggable glycosylation target in hepatocellular carcinoma}},
author = {Qin Ouyang and Ke Gao and Xinwen Zhou and Jieyi Shi and Long Liao and Cun Wang and Shu Zhang},
journal = {Molecular \& Cellular Proteomics},
year = {2026},
month = oct,
doi = {10.1016/j.mcpro.2026.101672},
url = {https://linkinghub.elsevier.com/retrieve/pii/S1535947626001684},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - SLC35A3 remodels site-specific N-glycosylation and defines a druggable glycosylation target in hepatocellular carcinoma
AU - Qin Ouyang
AU - Ke Gao
AU - Xinwen Zhou
AU - Jieyi Shi
AU - Long Liao
AU - Cun Wang
AU - Shu Zhang
PY - 2026
DA - 2026/10/01
JO - Molecular & Cellular Proteomics
DO - 10.1016/j.mcpro.2026.101672
UR - https://linkinghub.elsevier.com/retrieve/pii/S1535947626001684
SN - 1535-9476
ER -